Murine gut microbial interactions exert antihyperglycemic effects

Area of Science:

• Microbiology
• Metabolic Engineering
• Host-Microbiome Interactions

Background:

• Extensive research links gut microbiota to host metabolism, yet the role of microbial interactions remains underexplored.
• Understanding these interactions is crucial for developing targeted metabolic therapies.
• High-fat diets significantly alter gut microbial composition and host metabolic profiles.

Purpose of the Study:

• To identify specific gut microbes and their interactions affecting glucose and lipid metabolism.
• To investigate the impact of modulating gut microbial composition on host metabolism using a bacteriocin-targeting strategy.
• To explore potential therapeutic interventions for hyperglycemia through gut microbial manipulation.

Main Methods:

• Engineered Escherichia coli Nissle 1917 (EcN) to secrete a Listeria monocytogenes (Lmo)-derived bacteriocin (Lmo2776), creating strain EcN-2776.
• Administered EcN-2776 to mice fed a high-fat diet and analyzed changes in blood glucose, serum triglyceride, and gut microbial composition via 16S rRNA sequencing.
• Investigated the specific microbial interactions, including the effect of Lmo2776 on Ligilactobacillus murinus and Faecalibaculum rodentium.

Main Results:

• EcN-2776 administration reduced blood glucose and increased serum triglyceride levels in high-fat diet-fed mice.
• Lmo2776 secretion altered gut microbial composition, specifically restricting Ligilactobacillus murinus and enhancing Faecalibaculum rodentium.
• Faecalibaculum rodentium administration decreased fasting blood glucose, potentially through direct glucose consumption.

Conclusions:

• Identified specific gut microbes and their interactions that impact host glucose metabolism.
• Demonstrated that modulating gut microbial composition via bacteriocin secretion can influence host metabolic parameters.
• Findings suggest a novel therapeutic avenue for hyperglycemia targeting gut microbial interactions.